Tiotropium , a once-daily long-acting anticholinergic bronchodilator , when administered via Respimat SoftMist inhaler ( tiotropium Respimat ) significantly reduces the risk of severe exacerbations and improves lung function in patients with severe persistent asthma that is not fully controlled despite using inhaled corticosteroids ( ICS ) and long-acting 2-agonists .